---
title: "Cardiometabolic and Psychobehavioral Phenotypes Linked to Cardiovascular Risk in Rheumatoid Arthri"
id: "medrxiv-8-cardiometabolic-and-psychobehavioral-phenotypes-define-cardiovascular-risk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-cardiometabolic-and-psychobehavioral-phenotypes-define-cardiovascular-risk"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26363297v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cardiometabolic and Psychobehavioral Phenotypes Linked to Cardiovascular Risk in Rheumatoid Arthri
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-cardiometabolic-and-psychobehavioral-phenotypes-define-cardiovascular-risk
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26363297v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This NHANES-based analysis of 3,252 adults with self-reported **rheumatoid arthritis (RA)** used unsupervised clustering to identify distinct cardiovascular risk profiles. - Data from 2005–2018 were analyzed using partitioning around medoids (PAM) with Gower distance; cluster validity was assessed by silhouette analysis and internal train–test validation. - Six data-driven, clinically interpretable phenotypes emerged: **Severe Metabolic Diabetic**, **Aging Diabetic Hypertensive**, **Non-Diabetic Intermediate**, **Mild Metabolic**, **Cardiometabolic**, and **Smoking-Predominant**. - Phenotype prevalence estimates (survey-weighted) varied: Severe Metabolic Diabetic 40.3%, Aging Diabetic Hypertensive 34.9%, Non-Diabetic Intermediate 20.2%, Mild Metabolic 14.8%, Cardiometabolic 10.4%, Smoking-Predominant 19.4% (as reported in the source). - Compared with the **Cardiometabolic** phenotype, the Severe Metabolic Diabetic phenotype had the highest adjusted odds of prevalent **cardiovascular disease (CVD)** (aOR 4.11, 95% CI 2.56–6.59); Aging Diabetic-Hypertensive had aOR 3.38 (95% CI 2.22–5.15). - Elevated odds of prevalent CVD were also observed for the Smoking-Predominant (aOR 1.99, 95% CI 1.26–3.13) and Non-Diabetic Intermediate (aOR 1.77, 95% CI 1.10–2.84) phenotypes. - The six-cluster solution demonstrated moderate separation and consistent internal correspondence across training and testing sets; a phenotype-informed model showed moderate discrimination for prevalent CVD (AUC = 0.72). - The study suggests phenotype-based approaches may offer a multidimensional framework to characterize cardiovascular risk heterogeneity in people with RA and to inform targeted risk assessment or interventions.
## Clinical Analysis & Structured Key Points
Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis | medRxiv Skip to main content Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis Shah Tanzen Jahan , Anicha Akter , Sojib Hossain , Md Selim Reza , Md. Mijanur Rahman , Md. Mahmudul Alam , Md. Monimul Huq doi: https://doi.org/10.64898/2026.09.17.26363297 Shah Tanzen Jahan 1 Department of Statistics, University of Rajshahi, Bangladesh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anicha Akter 1 Department of Statistics, University of Rajshahi, Bangladesh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sojib Hossain 1 Department of Statistics, University of Rajshahi, Bangladesh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Md Selim Reza 2 Tulane University, New Orleans, Louisiana, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Md. Mijanur Rahman 3 School of Clinical Medicine, University of New South Wales (UNSW), Sydney, Australia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Md. Mahmudul Alam 1 Department of Statistics, University of Rajshahi, Bangladesh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Md. Monimul Huq 1 Department of Statistics, University of Rajshahi, Bangladesh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: monimul{at}ru.ac.bd Abstract Info/History Metrics Data/Code Preview PDF Abstract Abstract Cardiovascular disease (CVD) is a major cause of morbidity and premature mortality in people with rheumatoid arthritis (RA). Whether multidimensional cardiometabolic, inflammatory, renal, behavioral, and psychosocial factors define distinct cardiovascular risk phenotypes in RA remains unclear. This study aimed to identify data-driven phenotypes and evaluate their associations with prevalent CVD. We analyzed 3,252 adults aged over 20 years with self-reported RA from the 2005-2018 National Health and Nutrition Examination Survey (NHANES). Unsupervised partitioning around medoids (PAM) clustering using Gower distance identified distinct data-driven cardiovascular-risk profiles. Cluster validity was assessed using silhouette analysis and internal train test validation. Survey-weighted binary logistic regression evaluated associations between phenotype membership and prevalent CVD. Six clinically interpretable data-driven phenotypes were identified with varying CVD prevalence: Severe Metabolic Diabetic (40.3%), Aging Diabetic Hypertensive (34.9%), Non-Diabetic Intermediate (20.2%), Mild Metabolic (14.8%), Cardiometabolic (10.4%), and Smoking-Predominant (19.4%). Compared with the Cardiometabolic phenotype, the Severe Metabolic Diabetic phenotype exhibited the highest odds of prevalent CVD (aOR 4.11, 95%CI:2.56-6.59), followed by the Aging Diabetic-Hypertensive phenotype (aOR 3.38, 95%CI:2.22-5.15). Higher odds of prevalent CVD were also observed in the Smoking-Predominant (aOR 1.99, 95% CI: 1.26-3.13) and Non-Diabetic Intermediate (aOR 1.77, 95% CI: 1.10-2.84) phenotypes. The six-cluster solution demonstrated moderate separation and strong internal correspondence across training and testing sets, while the phenotype-informed model showed moderate discrimination for prevalent CVD (AUC = 0.72). Among adults with rheumatoid arthritis (RA), distinct data-driven phenotypes were identified based on combined patterns of metabolic, inflammatory, renal, behavioral, and psychosocial factors, with differing burdens of prevalent cardiovascular disease (CVD). Phenotype-based approaches may provide a comprehensive framework for characterizing multidimensional cardiovascular risk in RA. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The dataset(s) supporting the conclusions of this article are available in the National Health and Nutrition Examination Survey (NHANES) repository maintained by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), at https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx. All data analysed during the current study are publicly available and can be accessed without restriction. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The dataset(s) supporting the conclusions of this article are available in the National Health and Nutrition Examination Survey (NHANES) repository maintained by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), at https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx. All data analysed during the current study are publicly available and can be accessed without restriction. https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis Shah Tanzen Jahan , Anicha Akter , Sojib Hossain , Md Selim Reza , Md. Mijanur Rahman , Md. Mahmudul Alam , Md. Monimul Huq medRxiv 2026.09.17.26363297; doi: https://doi.org/10.64898/2026.09.17.26363297 Share This Article: Copy Citation Tools Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis Shah Tanzen Jahan , Anicha Akter , Sojib Hossain , Md Selim Reza , Md. Mijanur Rahman , Md. Mahmudul Alam , Md. Monimul Huq medRxiv 2026.09.17.26363297; doi: https://doi.org/10.64898/2026.09.17.26363297 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Rheumatology Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7066) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5060) Health Policy (1438) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16307) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7292) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (473) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5919) Public and Global Health (9770) Radiology and Imaging (2433) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (643) Sexual and Reproductive Health (773) Sports Medicine (581) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [LRX activatable fluorescence probe for real-time peroxynitrite imaging in diabetic wounds](https://medichelpline.com/clinical-feed/pubmed-42365674.md) (DOI: 10.1016/j.bioorg.2026.110177)
- [GLP-1 Receptor Agonists in Rheumatic Disease: Mechanisms, Evidence, and Clinical Considerations](https://medichelpline.com/clinical-feed/pubmed-42706128.md) (DOI: 10.3760/cma.j.cn112137-20260312-00692)
- [Brief-COPE Questionnaire Shows Five-Factor Structure in Seropositive Rheumatoid Arthritis](https://medichelpline.com/clinical-feed/medrxiv-1-validation-of-the-brief-cope-questionnaire-in-a-seropositive-rheumatoid.md)
- [Effectiveness and Safety of Tocilizumab in Refractory Rheumatoid Arthritis: A Moroccan Study](https://medichelpline.com/clinical-feed/medrxiv-12-real-world-effectiveness-and-safety-of-tocilizumab-in-refractory-rheumatoid.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.